| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |